Interleukin 2 receptor gamma gene targeting vector, production of immune cell-deficient transgenic cloned mini pig having vector introduced therein, preparation method therefor and use thereof
US-2016366861-A1 · Dec 22, 2016 · US
US2016341727A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016341727-A1 |
| Application number | US-201614994042-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 12, 2016 |
| Priority date | Aug 17, 2010 |
| Publication date | Nov 24, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method to identify a peptide and/or its encoding DNA, wherein the peptide binds to a T-cell receptor and/or an NK-cell receptor and/or an NKT-cell receptor, the method comprising: providing a carrier to which is attached a peptide and its encoding DNA; providing an MHC and/or an MHC-like molecule; and exposing the peptide to a T-cell receptor and/or an NK-cell receptor and/or an NKT-cell receptor in the presence of the MHC or MHC-like molecule.
Opening claim text (preview).
1 .- 20 . (canceled) 21 . A carrier to which is attached a peptide, DNA encoding the peptide, and β2 microglobulin. 22 . The carrier of claim 21 to which an MHC or MHC-like molecule is attached. 23 . The carrier of claim 21 wherein the β2 microglobulin is attached to the carrier as part of a larger construct which includes the peptide. 24 . The carrier of claim 21 wherein the peptide and β2 microglobulin are provided connected by a flexible linker. 25 . The carrier of claim 21 wherein the peptide is between about 4 and about 20 amino acids. 26 . The carrier of claim 21 wherein the carrier is a solid support. 27 . The carrier of claim 21 wherein the carrier is a bead. 28 . The carrier of claim 21 wherein the carrier is multivalent. 29 . A carrier to which is attached a peptide, DNA encoding the peptide, and β2 microglobulin and/or an MHC or MHC-like molecule. 30 . The use of a carrier according to claim 21 to identify an epitope recognised by a T-cell receptor and/or an NK-cell receptor and/or an NKT-cell receptor. 31 . A kit for screening for a T-cell epitope and/or an NK-cell epitope and/or an NKT-cell epitope, wherein the kit comprises a carrier to which is attached a peptide, DNA encoding the peptide and β2 microglobulin. 32 . The kit of claim 31 further including instructions to fold the peptide and β2 microglobulin.
the carrier being characterised by its particulate form · CPC title
White blood cells · CPC title
MHC-molecules, e.g. HLA-molecules · CPC title
HLA or MHC typing · CPC title
Protein x Protein interaction, e.g. two hybrid selection · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.